CytomX Therapeutics Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy signal from moving average indicating potential upward movement.
Sell Signal (MA)
Sell signal from moving average indicating potential downward movement.
AI Analysis of CTMX
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
Stronger technical forecast for CytomX Therapeutics stock price after Friday trading
(Updated on Oct 11, 2024)
Hold candidate since Oct 11, 2024
The CytomX Therapeutics stock price gained 2.68% on the last trading day (Friday, 11th Oct 2024), rising from $1.12 to $1.15. During the last trading day the stock fluctuated 3.59% from a day low at $1.11 to a day high of $1.15. The price has fallen in 5 of the last 10 days and is down by -4.17% for this period. Volume fell on the last day by -504 thousand shares and in total, 337 thousand shares were bought and sold for approximately $388.09 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.82% during the next 3 months and, with a 90% probability hold a price between $0.82 and $1.04 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
CTMX Signals & Forecast
There are mixed signals in the stock today. The CytomX Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.19. On a fall, the stock will find some support from the short-term average at $1.14. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Tuesday, September 03, 2024, and so far it has risen 2.68%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for CytomX Therapeutics stock
CytomX Therapeutics finds support from accumulated volume at $1.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0399 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 3.66%.
Our recommended stop-loss: $1.09 (-5.07%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 28 days ago.)
Trading Expectations (CTMX) For The Upcoming Trading Day Of Monday 14th
For the upcoming trading day on Monday, 14th we expect CytomX Therapeutics to open at $1.14, and during the day (based on 14 day Average True Range), to move between $1.09 and $1.21, which gives a possible trading interval of +/-$0.0591 (+/-5.14%) up or down from last closing price. If CytomX Therapeutics takes out the full calculated possible swing range there will be an estimated 10.28% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.14 (0.87%) than the resistance at $1.19 (3.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is CytomX Therapeutics stock A Buy?
CytomX Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score:
-0.020
Hold/Accumulate
Upgraded
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on October 14, 2024 - $1.14 ( 1.16%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for CTMX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.18 | 2.31% |
| R2 | 1.16 | 0.99% |
| R1 | 1.15 | 0.169% |
| Price | 1.15 | |
| S1 | 1.12 | -2.48% |
| S2 | 1.11 | -3.30% |
| S3 | 1.10 | -4.63% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.42 | 23.48% |
| R2 | 1.20 | 4.35% |
| R1 | 1.19 | 3.48% |
| Price | 1.15 | |
| S1 | 1.14 | -0.87% |
| S2 | 1.13 | -1.74% |
| S3 | 1.12 | -2.61% |
FAQ
Click here for our free guide on how to buy CytomX Therapeutics Stock.
